Drug induced aseptic meningitis: Difference between revisions

No edit summary
No edit summary
Line 24: Line 24:
**OKT3 monoclonal antibodies
**OKT3 monoclonal antibodies
*Misc
*Misc
**[[Sulfasalazine]]
**Sulfasalazine
**[[Carbamazepine]]
**[[Carbamazepine]]
**[[Azathioprine]]
**[[Azathioprine]]
Line 31: Line 31:
**[[Ranitidine]]
**[[Ranitidine]]
**[[Famotidine]]
**[[Famotidine]]
**[[Methylprednisolone acetate]]
**Methylprednisolone acetate
**[[Allopurinol]]
**[[Allopurinol]]



Revision as of 16:09, 12 September 2017

Background

  • Abbreviation: DIAM
  • Two proposed mechanisms
    • Direct meningeal irritation by intrathecal drug
    • Hypersensitivity reaction to drug (type III and IV)
  • Higher predominance in SLE and female gender

Causes

Clinical Freatures

Differential Diagnosis

Headache

Common

Killers

Maimers

Others

Aseptic Meningitis

Evaluation

  • Drug history with focus on time of ingestion and symptom onset
  • CSF studies
    • Pleiocytosis (primarily neutrophilic)
    • Elevated protein levels
    • Normal glucose
    • Negative cultures
  • Challenge test with suspected drug
    • Only confirmatory test
    • Requires informed written consent
    • Due to associated risk, should only be done if suspected drug is irreplaceable

Management

  • Discontinuation of offending agent

Disposition

See Also

References